Aquestive Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 9.81 M | $63.38 M | 0.00% | 8.87% |
| BLACKROCK, INC. | 02/12/2026 | 7.78 M | $50.23 M | 19.15% | 7.03% |
| RTW INVESTMENTS, LP | 02/17/2026 | 6.25 M | $40.38 M | 0.00% | 5.65% |
| VANGUARD GROUP INC | 01/29/2026 | 5.89 M | $38.06 M | 4.07% | 5.33% |
| ECOR1 CAPITAL, LLC | 02/17/2026 | 2.63 M | $16.96 M | 0.00% | 2.37% |
| SAMSARA BIOCAPITAL, LLC | 02/17/2026 | 2.50 M | $16.15 M | 0.00% | 2.26% |
| STATE STREET CORP | 02/13/2026 | 2.46 M | $15.91 M | 53.71% | 2.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.37 M | $15.30 M | 13.42% | 2.14% |
| FEDERATED HERMES, INC. | 02/12/2026 | 2.03 M | $13.13 M | 159.36% | 1.84% |
| MORGAN STANLEY | 02/13/2026 | 1.76 M | $11.36 M | 24.72% | 1.59% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.54 M | $9.92 M | 19.08% | 1.39% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.21 M | $7.80 M | -1.19% | 1.09% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 1.19 M | $7.68 M | 804.61% | 1.07% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 1.17 M | $7.57 M | 6,233.38% | 1.06% |
| JANNEY MONTGOMERY SCOTT LLC | 02/11/2026 | 1.09 M | $7.06 M | -0.60% | 0.99% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/12/2026 | 1.02 M | $6.59 M | -3.68% | 0.92% |
| HRT FINANCIAL LP | 02/12/2026 | 994.97 K | $6.43 M | 77.61% | 0.90% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 993.10 K | $6.42 M | -33.71% | 0.90% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 970.94 K | $6.27 M | 100.00% | 0.88% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 941.20 K | $6.08 M | 3,590.97% | 0.85% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 909.06 K | $5.87 M | 130.06% | 0.82% |
| ABRDN PLC | 01/16/2026 | 809.20 K | $5.23 M | 29.47% | 0.73% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 747.19 K | $4.83 M | -80.13% | 0.68% |
| NORTHERN TRUST CORP | 02/17/2026 | 742.79 K | $4.80 M | 8.78% | 0.67% |
| WASATCH ADVISORS LP | 02/12/2026 | 681.24 K | $4.40 M | -5.94% | 0.62% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 587.25 K | $3.79 M | -46.06% | 0.53% |
| CITADEL ADVISORS LLC | 02/17/2026 | 570.95 K | $3.69 M | -25.70% | 0.52% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 554.90 K | $3.58 M | 254.57% | 0.50% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/20/2026 | 525.00 K | $3.39 M | -58.00% | 0.47% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 523.33 K | $3.38 M | 100.00% | 0.47% |
| JANE STREET GROUP, LLC | 02/12/2026 | 512.22 K | $3.31 M | 592.63% | 0.46% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 500.00 K | $3.23 M | 100.00% | 0.45% |
| BRACEBRIDGE CAPITAL, LLC | 02/17/2026 | 459.22 K | $2.97 M | 0.00% | 0.42% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 414.40 K | $2.68 M | 376.32% | 0.37% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 381.12 K | $2.46 M | 100.00% | 0.34% |
| JPMORGAN CHASE & CO | 02/11/2026 | 379.42 K | $2.45 M | -19.88% | 0.34% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 375.92 K | $2.43 M | -26.66% | 0.34% |
| STIFEL FINANCIAL CORP | 02/13/2026 | 369.73 K | $2.39 M | 0.90% | 0.33% |
| NUVEEN, LLC | 02/12/2026 | 364.02 K | $2.35 M | -33.16% | 0.33% |
| EVERSTAR ASSET MANAGEMENT, LLC | 02/05/2026 | 344.80 K | $2.23 M | -6.38% | 0.31% |
| BARCLAYS PLC | 02/13/2026 | 340.81 K | $2.20 M | 158.66% | 0.31% |
| DIADEMA PARTNERS LP | 02/17/2026 | 337.70 K | $2.18 M | 100.00% | 0.31% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 332.40 K | $2.15 M | 100.00% | 0.30% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 301.52 K | $1.95 M | 18.63% | 0.27% |
| UBS GROUP AG | 01/29/2026 | 296.45 K | $1.92 M | -40.60% | 0.27% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 287.81 K | $1.86 M | -43.04% | 0.26% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 270.98 K | $1.75 M | -5.18% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 269.82 K | $1.74 M | 30.20% | 0.24% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 254.00 K | $1.64 M | 100.00% | 0.23% |
| JUMP FINANCIAL, LLC | 02/17/2026 | 246.84 K | $1.59 M | 1,098.37% | 0.22% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aquestive Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 234 institutional investors and hedge funds held shares of Aquestive Therapeutics Inc. The most heavily invested institutionals were:
FEDERATED HERMES, INC.: 2.94 M
Janney Montgomery Scott LLC: 1.09 M
COMMONWEALTH EQUITY SERVICES, LLC: 1.08 M
WELLS FARGO & COMPANY/MN: 1.03 M
JANE STREET GROUP, LLC: 1.03 M
WASATCH ADVISORS LP: 878,316
65.28% of Aquestive Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 81.54 M shares in the last 24 months. This purchase volume represents approximately $349.80 M in transactions.